- Home
- DFIN vs TVTX Comparison
DFIN vs TVTX Comparison
Compare DFIN & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFIN
- TVTX
- Stock Information
- Founded
- DFIN 1983
- TVTX 2008
- Country
- DFIN United States
- TVTX United States
- Employees
- DFIN N/A
- TVTX N/A
- Industry
- DFIN Other Consumer Services
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- DFIN Consumer Discretionary
- TVTX Health Care
- Exchange
- DFIN Nasdaq
- TVTX Nasdaq
- Market Cap
- DFIN 1.6B
- TVTX 1.5B
- IPO Year
- DFIN N/A
- TVTX N/A
- Fundamental
- Price
- DFIN $53.38
- TVTX $23.84
- Analyst Decision
- DFIN Strong Buy
- TVTX Strong Buy
- Analyst Count
- DFIN 3
- TVTX 16
- Target Price
- DFIN $68.67
- TVTX $35.20
- AVG Volume (30 Days)
- DFIN 219.4K
- TVTX 2.7M
- Earning Date
- DFIN 10-30-2025
- TVTX 10-30-2025
- Dividend Yield
- DFIN N/A
- TVTX N/A
- EPS Growth
- DFIN N/A
- TVTX N/A
- EPS
- DFIN 2.79
- TVTX N/A
- Revenue
- DFIN $755,000,000.00
- TVTX $333,865,000.00
- Revenue This Year
- DFIN N/A
- TVTX $83.26
- Revenue Next Year
- DFIN $4.66
- TVTX $43.19
- P/E Ratio
- DFIN $19.17
- TVTX N/A
- Revenue Growth
- DFIN N/A
- TVTX 87.94
- 52 Week Low
- DFIN $37.80
- TVTX $12.91
- 52 Week High
- DFIN $70.55
- TVTX $28.69
- Technical
- Relative Strength Index (RSI)
- DFIN 40.89
- TVTX 64.03
- Support Level
- DFIN $52.66
- TVTX $22.65
- Resistance Level
- DFIN $54.67
- TVTX $28.69
- Average True Range (ATR)
- DFIN 1.40
- TVTX 1.44
- MACD
- DFIN -0.19
- TVTX 0.18
- Stochastic Oscillator
- DFIN 17.41
- TVTX 57.52
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.